Amundi Index Solutions - Amundi Index MSCI Europe ME-CRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 17.6 | -4.1 | 13.3 | 5.3 | |
+/-Cat | -2.1 | 2.3 | 4.2 | 1.7 | 1.6 | |
+/-B’mrk | -0.3 | -0.1 | 0.4 | 0.1 | -0.1 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 21/11/2024 | EUR 420.69 | |
Day Change | 0.82% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0389811703 | |
Fund Size (Mil) 21/11/2024 | EUR 4192.30 | |
Share Class Size (Mil) 21/11/2024 | EUR 2.90 | |
Max Initial Charge | 2.50% | |
Ongoing Charge 22/06/2024 | 0.20% |
Investment Objective: Amundi Index Solutions - Amundi Index MSCI Europe ME-C |
To track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Isabelle Lafargue 07/09/2015 | ||
Inception Date 24/11/2008 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index MSCI Europe ME-C | 20/11/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.24 |
ASML Holding NV | Technology | 2.50 |
SAP SE | Technology | 2.34 |
Nestle SA | Consumer Defensive | 2.18 |
Shell PLC | Energy | 1.96 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index MSCI Europe ME-C |